protein of feline ~mmu~ode~c~en~y virus (FIV) fused with maltose binding protein ~SL32~~-~~G~~ were ~o~tru~ted using an invertible promoter system that allows the stable expression of heterologous antigens at levels toxic for bacteria. A SL3241 strain expressing the B subunit of cholera toxin by a similar system (SL3261-CtxB) served as a control in FIV-immunization experiments. Cats immunized once orally or intraperitoneally with SL3261-MFG or SL326l-CtxB all developed serum antibodies to SL3261 l~popolysa~~har~de and against maltose birding protein or the B subunit of cholera toxin, respe~ti~3e~y. Two ~ntra~er~tonea~ ~mman~zatio~ with SL32~~-~FG also resulted in the development of Gag spectjk serum antibodies. Two oral immunizations with SL3261-MFGprimedfor a Gag specific response, which was demonstrated upon FIV challenge. All challenged cats became infected and no signtjicant dtrerences in viral loads were found between SL3261-MFG and SL3261-CtxB immunized cats. 0 1991 Hsevier Science Ltd.
Feline immunodeficiency virus (FIV) infection of cats shows many similarities with human (HIV) and simian i~unode~~ien~y virus (SIV) infections. It infects its natural host persistently, is T lymphotropic, causes a progressive loss of CD4* T cells, can infect macrophages and astrocytes, and eventually causes severe immunodeficiency or feline AIDSlp6. Because of these similarities, FIV infection of cats is considered a useful small-animal model for the evaluation of vaccine strategies relevant for controlling HIV-1 infection of humans.
In the search for effective lentivirus vaccines different strategies like inactivated complete virus7, subunits'-'", peptidesi3, live attenuated virus'"", viral carriers'8-20, bacterial carriers"-" and nucleic acid immunizations'"-are being explored. In the FIV-cat system, vaccination of cats with paraformaldehyde fixed T cells (FL-4 cells) persistently infected with FIV and with paraformaldehyde inactivated FIV derived from the same cells, proved to be protective against homologous and to a lesser extent heterologous challenge25326. In the SIV-macaque system, vaccination with whole inactivated virus induced partial protection against challenge with PBMC from a SIVmac infected macaque*'. Earlier reported protection against challenge with cell-free virus after immunizing with inactivated whole SIVmac was almost certainly mediated by the immune response to cellular proteins incorporated into both the immunogen and the challenge viruse~~'~~~. To date, the most effective protection of macaques against SIV infection has been obtained with live attenuated SIV14329. However, safety issues are still a major subject of debatei7. Live recombinant carriers like pox-viruses, BCG and attenuated ~~~~~~~1~~ strains are being evaluated as alternative approaches for lentivirus vaccine development. Attenuated Salmonella strains have been used successfully to present heterologous bacteria130~31y vira132-34 and protozoa135-"7 antigens to the immune system of mammals. Systemic humoral and cellular responses, including class I restricted cytotoxie T lymphocytes (CTL), and mucosal humoral responses have been shown to result from vaccination with recombinant Salmonella strains35,38-4".
The development of Salmonella bacteria as carriers for heterologous antigens has largely been hampered by problems with stability of expression or production levefs caused by the toxicity of the antigens for the induction of FiV specific antibodies in cats: E.J. T@aar et al.
px.F:
-yJ;_ malE p Figure 1 The two ptasmid invertible promoter system. P,, Jeftward promoter of bacteriophage lambda; IR, inverted repeat; Tl I m-B T1 transcription terminator; gin, invertase gene; ct587, phage lambda temperature sensitive repressor protein gene; Kan, ka~my~in resistance gene; Ap, ampicillin resistance gene; malE, gene coding for maltose binding protein; TTpol, T7 RNA polymerase gene; P,, gene-l0 promoter of bacteriophage T7. The Invertible promoter of plP controls transcription of the T7 RNA polymerase gene, which in turn directs transcription of a gene located under control of the P,, promoter on a second plasmid [e.g. pETMALp, pETMALgag (not shown) or pT7ctxB (not shown)]. In this study four different PIPvectors (plF2, were used. The vector plP3 (=pYZUGF) differs from plP2 (=pYZ27bGF) by having an additional adenine in the untranslated leader sequence af the gin gene. The vectors plF4 and plP5 are derivatives from piP2, respectively plP3, in which the p75A origin of replication (on) that results in an intermediate copy number, is replaced by the on' and pa~~t~oning (par) region of the tow copy number pfasmid pSCIOl. The parregion ensures equal distribu~on of the plasmid over the daughter cells during cell division producing Salmonella strains. Especially expression of non-bacterial antigens may cause problems due to different codon usage or the presence of toxic (e.g. hydrophobic) sequences. Therefore we42--15 developed a system that allows the stable expression of antigens at levels toxic for individual bacteria. The system is based on an invertible promoter that controls the expression of T7 RNA polymerase. A single promoter inversion results in expression of T7 RNA polymerase, which in turn directs expression from genes located under the contro1 of a T7 promoter present on another vector in the same cell (i"'igure 1). The key feature of the system is that the promoter controlling the T7 RNA polymerase expression inverts with a frequency that results in toxic levels of antigen expression in only a sub-population of the bacteria. Therefore the major part of the bacterial population will not be affected by expression of the heterologous antigen and will continuously segregate new antigen-producing bacteria.
Here we describe the use of this invertible promoter system to express high levels of FIV core protein as a fusion with the maltose binding protein (MBF) in the S. &~~~~rn~r~~rn uroA vaccine strain SL3261 and the use of this strain to induce specific immunity in cats.
MATERIAL AND METHODS

Bacterial strains, plasmids and media
Exherichiu coli strain DH5a (BRL Life Technologies, Breda, The Netherlands) was used as a host for all plasmid constructions. Before introduction into the S. typhimurium aroA vaccination strain SL326146 plasmids were passaged through the restriction deficient, modification proficient S. ~y~~~rn~ri~rn strain SL5283, a gaiE503 derivative of LE500~47,4*.
Strain BL~~DE~L~sS~~ is a lysogen of the E. co& strain BL2I that contains a copy of the T7 RNA polymerase gene in the chromosome under control of the IPTG inducible la&V5 promote?' and the pLysS plasmid which codes for T7 lysozyme; a natural inhibitor of T7 RNA polymerase. Strain BL2lDEpLysS was used to express genes under the control of a T7 promoter. The T7 RNA lysozyme, encoded by pLysS, reduces the basal activity of T7 RNA polymerase in uninduced cells, thereby allowing the establishment of target genes whose basal expression would otherwise have been toxic to the cells. The vector pLysS confers resistance to ~hlor~pheni~ol and is compatible with plasmids containing a ColEf origin of replication4'. All bacteria were grown aerobically at 37°C in Luria broth (LB), unless indicated otherwise. Ampicillin was used at 100 pg ml-' in LB agar plates and 200 pg ml-' in liquid media. Kanamycin and chlo~amphenicol were used at concentrations of 50 ,ug ml -' and 35 pug ml-', respectively, in agar plates as well as in liquid media.
Construction of the plasmids pYZ27bGP (=pIP2), pYZ27GP (-pIP3), pIP4 and PIPS has been described 43s4 previausly
. The vectors pET3xa49 and pMal-p were purchased from Invitrogen and New England Biolabs, respectively.
Isolation of plasmid DNA, preparation of DNA fragments and ligations were carried out using standard method8'. Plasmids were introduced into bacteria by electroporation as previously described44.
Construction of plasmids used in this study
To increase the copy number of pET3xaa9 the rep gene, which negatively regulates plasmid copy numbers of ColE 1 based plasmids, was removed by cleavage with Bg&I and PvuIl, foibwed by blunting of the ends with T4 DNA polymerase and religation of the plasmid, From the resulting plasmid, designated pET3xa1, a number of inconvenient restriction sites were removed by cleavage with EcoRT and EcoRV followed by blunting with T4 DNA polymerase and religation. The resulting plasmid was designated pET3xa2. The malE gene, which codes for precursor maltose binding protein (preMBP), was obtained by PCR using pMal-p (cat #800-61, New England Biolabs, Inc., Beverly, MA, USA) as template and the oligo nucleotides S-CGAG~CJW&~_~AAAATAAAAACAGGTGCACG-3' and 5'-CAATTCAGGCCTACCC TCGATGGATCC-3' as amplimers. The first ampfimer was designed to introduce a N&I site (~derlined) at the position of the ATG start codon of ma/E. The second amplimer overlapped partially with the multiple cloning site (MCS) of p!$AL-p, so that the PCR product would contain the 5'-part of the MCS, which includes a unique KpnI site, The PCR product was cleaved with NdeI and KpnI and cloned into the corresponding sites of pET3xa2 to generate pETMALp ( Figure I ). In this plasmid transcription of the m&E gene is under the control of the T7 promoter.
The vector pETMALgag was constructed by replacing the small NcoI-BamHI fragment of pETMALp (Figwe 1) by the ~co~-~ffrnH~ fragment of pMAL-gag, which contained the 3'-end of the ma/E gene in frame with the complete coding part of the gag gene of the molecular FIV clone 19kl. In pETMALgag, transcription of the malE-gag fusion is under the control of the T7 promoter.
Western blot analysis of bacteria
For Western blot analysis SDS-PAGE was immediately followed by transfer of the proteins to nitrocellulose. Blots were incubated for 30 min at room temperature with blocking buffer (BB) [0.5% Tween-20 and 0.5% low fat milk powder in PBS]. Subsequently, the blots were incubated for 1 h at room temperature with serum of an experimentally infected SPF cat (cat 89176), diluted 100 times in BB. After washing 3 times over a period of 30 min in PBS containing 0.5% Tween-20, the blot was incubated for 1 h at room temperature with a biotinylated anti-cat IgG monoclonal (Sigma Immuno Chemicals, clone CT-21, cat.nr. B-226) diluted in BB. After washing, the blot was incubated for 30 min at room temperature with alkaline phosphatase conjugated ExtrAvidin (Sigma Immuno Chemicals, cat.nr. E2636) diluted in BB. Finally the blot was washed three times, soaked for 10 min in substrate buffer (0.1 M Tris pH 9.5, 0.1 M NaCl, 0.05 M MgCl,) and developed in substrate buffer containing Nitro Blue Tetrazolium (NBT) and 5-Bromo-4-Chloro-3-Indolyl Phosphate (BCIP).
Detection of antigen expression by electron microscopy
To obtain an indication of the percentage of bacteria of strain SL3261-MFG4 (Table I) that, due to a promoter inversion, expressed the MBP-Gag fusion protein, bacteria were grown in the presence of ampicillin and kanamycin until they reached the logarithmic phase. Subsequently, the bacteria were spun down (13,000 rpm) for 2 min, washed once with ice cold PBS and fixed with 4% paraformaldehyde in 0.1 M NaCacodylate (pH 7.4). Then the bacteria were transferred to 2% gelatine, impregnated in 2.3 M sucrose and frozen in liquid nitrogen.
Finally ultra thin cryosections were made. The cryosections were subjected to immunogold labelling using the Gag specific moAB 2-l 152 diluted 100 x in PBS containing 0.5% BSA and 0.1% gelatine, and protein A conjugated to gold particles with a diameter of 10 nm (Aurion, Wageningen, The Netherlands, nr. 110.111) diluted 20 x in the same buffer. The sections were stained and embedded into methyl cellulose according to the method of Tokuyasu53. Subsequently, the sections were analysed by transmission electron microscopy (Phillips EM400). Bacteria were arbitrarily classified according to the amount of labelling. For this determination only complete longitudinal cross sections of bacteria were used.
Plasmid stability of bacterial strains during growth in thymocytes
The assay for determination of plasmid stability of SL3261 strains after invasion of eukaryotic cells was essentially performed as described previously45. In short, thymocytes derived from a specified pathogen free (SPF) cat were stimulated for 3 days with Concanavalin A, washed and subsequently maintained in culture medium
Cetus) at 37"C/5% CO,. About 10' bacteria from logarithmic phase cultures were added to lo6 thymocytes in a total volume of 1 ml RPM1 1640 without any additives. After 2 h incubation at 37°C the cells were washed and subsequently maintained at 37X/5% CO, in 10 ml culture media containing gentamicin (50 pg ml-') to kill extracellular bacteria. After 24 h the plasmid stability was determined by lysing the thymocytes and comparing the number of CFUs that could be recovered on plates without and with the appropriate antibiotics.
Immunization and FIV challenge of cats
For immunization, bacteria from logarithmically growing cultures were harvested by centrifugation, washed, and resuspended in PBS. Subsequently, six months old specified pathogen free (SPF) cats, without detectable antibody levels against Salmonella LPS or CtxB, received 4 ml of 2.5 x 10' cells ml-' by the intraperitoneal (i.p.) route or 10 ml of 5 X 10" cells ml-' directly into the stomach to simulate oral administration.
This "oral" immunization was performed with anaesthetized cats using a syringe connected to a thin tube that reached into the stomach. Just prior to oral administration of the bacteria, gastric juices were neutralized by administration of 10 ml 10% NaHCO,, using the same device.
Two cats were immunized with SL3261 expressing Gag, one cat by the oral route and the other by the i.p. route. The primary immunization (week 0) was performed with SL3261-MFG4, whereas the secondary immunization (week 9) was performed with equal amounts of strains SL3261-MFG2 and SL3261-MFG4 (Table I) . As a control, two cats were immunized with the CtxB expressing strain SL3261-CtxB (Table I) at week 0 and 9. Again, one cat was immunized by the oral route and the other by the i.p. route. Eighteen weeks after the primary immunization all cats were challenged intramuscularly with 30 ID50 of the molecular FIV clone 19kl .
54 Serum samp es 1 were taken at 1, 2, 3, 4, 5, 9, 10, 13 and 15 weeks after the primary immunization, immediately prior to FIV challenge and 4, 7, 10, 14, 19, 24, 28, 33 and 67 days post challenge. 
Detection of FIV infection
CtxB-ELISA.
The ELISA for the detection of CtxB specific antibodies differed from the LPS-ELISA in the coating step, which was performed in PBS containing 5.0 ,ug ml-' CtxB (List Biological Labs, Campbell, CA, USA) and the dilutions of the biotinylated anti-cat IgG monoclonal antibody (1:2000) and the streptavidin HRP-conjugate
(1:2500). In addition the ELISA-buffer in which the cat sera were diluted, was supplemented with 1% SL3261 sonificate prepared from a 50 times concentrated o/n bacterial culture to reduce background reactions. The titer was defined as the highest dilution of test samples at which the O.D. 450 was at least three times higher than that of the corresponding serum dilution of the control cat immunized in a similar way with SL3261 expressing MBP-Gag instead of CtxB.
MBP-ELZSA.
The ELISA for the detection of MBP specific antibodies was performed identical to that for CtxB except that for the coating step 3.0 ,ug ml-' MBP was used.
The MBP was isolated from strain DHSa(pMALc) by affinity chromatography with maltose-Sepharose using a commercially available kit (Protein Fusion and Purification System, cat #800, New England Biolabs, Inc., Beverly, MA, USA). The titer was defined as the highest dilution of test samples at which the O.D. 450 was at least two times higher than that of the corresponding serum dilution of the control cat immunized in a similar way with SL3261 expressing CtxB instead of MBP-Gag.
Gag-ELISA.
Antibody titers against p17 and p24 core proteins were determined using a commercially available ELISA (FIV-p24/p17 antibody test kit, cat. nr. F1002-ABOl, European Veterinary Laboratory BV, Woerden, The Netherlands).
RESULTS
Expression of FIV-Gag
For use in the two plasmid invertible promoter system (Figure I ), the malE gene was placed under the control of the T7 promoter. The resulting plasmid, designated pETMALp ( Figure I ), was transferred to the E. coli strain BL21DEpLysS which contains on its chromosome the T7 RNA polymerase gene under control of the IPTG inducible lacUV5 promoter. Five hours after the addition of 1 mM IPTG to logarithmically growing bacteria, cells were harvested and total bacterial lvsates were subjected to SDS-PAGE followed by staining of the gel. Lanes: 1. molecular weioht markers: 2. BL21DEpLvsS:
3. BL~~DEDLvsS (pETMALp). Nimbers on the left refer to the molecular sizes'of-the marker proteins in kDa IPTG-induction of the T7 RNA polymerase gene in BL2 1 DEpLysS(pETMALp) resulted in the expression of the malE gene (Figure 2) . A prominent band with a Mw corresponding to preMBP, as well as a weaker band with a Mw corresponding to MBP from which the signal sequence had been cleaved-off, were visible on a Coomassie Blue stained SDS-PAGE gel. To obtain high expression levels of the gag gene of the molecular clone FIV 19k1, it was cloned in frame with the malE gene of pETMALp and the resulting plasmid was designated pETMALgag. The plasmid pIP2 (=pYZ27bGP) ( Figure  I ) contains the T7 RNA polymerase gene under control of an invertible Pi_-promoter.
S. typhimurium strain SL3261, harbouring pETMALgag in combination with pIP2, designated SL3261-MFG2, expressed high amounts of the MBPGag fusion protein ( Figure 3A) . The presence of the Gag-moiety of this fusion protein was confirmed by Western blotting which shows the full-length MBP-Gag band and a number of break-down products ( Figure 3B ).
Inversion frequency and plasmid stability
Previously"' it had been demonstrated that pIP3, which differs from pIP2 by having an extra nucleotide in the untranslated leader sequence of gin, reveals slightly lower expression levels of genes under the control of a T7-promoter than pIP2. The vectors pIP4 and pIP5 are lower copy number derivatives of pIP2 and pIP3, respectively, which reveal significantly lower expression levels than the parental plasmids. The PIP-vectors were analyzed by SDS-PAGE ( Figure 4A ) and Western blotting ( Figure 4B) . Three individual clones were tested for each of the plasmid combinations.
The highest MBP-Gag production was obtained for SL326 1 -MFG2, followed by SL3261-MFG3 and SL3261-MFG4, which reveal comparable expression levels, and finally SL3261-MFGS. The plasmid stability of SL3261 strains after growth lost one or both plasmids within 24 h. Furthermore, the in eukaryotic cell lines gives an indication of the in viva bacteria that still contained both plasmids, appeared to plasmid stability45. Therefore the plasmid stability of be mutants that did not express the fusion protein. In the SL3261-MFG strains was determined in cat thymocontrast, the combinations of pETMALgag with pIP4 cytes cultured in vitro (Table 3) . In this invasion assay or pIP5 were relatively stable and all the tested bacteria pETMALgag alone was stably maintained in SL3261, still expressed the MBP-Gag fusion protein. but the combinations of pETMALgag with pYZ27bGP Of the two stably expressing strains the highest ex-(=pIP2), and pYZ27GP (=pIP3) expressed the MBP-Gag fusion protein in this strain, bacteria from logarithmic growth cultures were fixed, immunogold labelled on ultra-thin cryosections and analysed by means of transmission electron microscopy. Bacteria were arbitrary classified according to the amount of labelling ( Figure 5 ). Of the cells of the negative control strains SL3261 and SL3261-CtxB, 94% and 92% were not labelled, respectively. The remaining 6% and 8% respectively, were labelled with only one to three gold particles. Of strain SL3261-MFG4 53% of the cells were not labelled, 30% contained one to three gold particles and 17% contained more than 3 particles, with an average of 10.5 particles/bacterium.
Induction of F/V specific antibodies in cats: E.J. TJhaar
Taking the 7% background labelling of the control strains into consideration, the percentage cells from strain SL3261-MFG4 expressing MBP-Gag is approximately 40% (=30 -7+ 17) of the total population.
Immonogenicity of SL3261-MFG and SL3261-CtxB in the cat
Two cats were immunized with SL3261-MFG4 and two cats with strain SL3261-CtxB, which previous1 induced high titers of CtxB specific antibodies in mice4 Y . Within each group one of the cats was immunized orally and the other one intraperitoneally (i.p.) ( Table 2 ). All animals developed antibodies to S. typhimurium LPS within one week after the first immunization (Figure 6a ).
After administration
of SL3261-CtxB, high anti-CtxB serum titers were induced (Figure 6b ). After the primary immunization with SL3261-MFG4, considerable anti-MBP IgG titers were induced in the i.p. immunized cat ( Figure 6~ ). The orally immunized cat developed a weak specific IgG response after the first immunization, but the second immunization at week 9 resulted in a considerably increased response. After the primary immunization with SL3261-MFG4, no antibodies specific for the Gag-moiety of the MBPGag fusion protein could be detected. This strain was selected for the primary immunization, because the plasmids in this strain were relatively stable in the invasion assay (see Table 3 ). The second immunization was performed with equal amounts of SL3261-MFG4 and SL3261-MFG2.
Although the plasmid combination of SL3261-MFG2
was not stably maintained in the invasion assay, it was incorporated in the second immunization because it expressed higher levels of MBP-Gag. The idea was that SL3261-MFG2
would present a higher amount of MBP-Gag early in infection, while SL3261-MFG4 would give a lower but more stable expression.
One week after the second immunization Gag-specific antibodies were detected in the serum of the cat immunized by the i.p. route (Figure 6d ). No Gagspecific antibodies were detected in the serum of the orally immunized cat.
To determine whether immunization with SL3261-MFG had induced protective cellular immune responses, all cats were challenged intramuscularly with 30 ID50 of the homologous molecular clone FIV 19k1, eighteen weeks after the first immunization.
Between 14 to 19 days post challenge (p.c.) all the animals had developed a persistent viraemia (Table 4) . No significant differences in viral load were observed between the cats immunized with SL3261-MFG or SL3261-CtxB (Table 5 ). Both cats immunized with the SL3261-MFG strains developed an anamnestic response to Gag as antibody titers to Gag started to rise two weeks earlier in these cats than in the cats immunized with SL3261-CtxB (Figure 6d ).
DISCUSSION
In the present paper we have shown that the S. typhimurium strain SL3261 can be used efficiently as a vector to present heterologous antigens to the feline immune system. Cats immunized with SL3261-MFG developed a Gag specific immune response, but were not protected from intramuscular challenge with the homologous molecular clone FIV 19kl.
The development of candidate vaccines based on recombinant Salmonella as live carriers, has largely been hampered by the inability to stably express heterologous antigens at levels that are toxic for the producing bacteria. However, we previously45 described a two plasmid invertible promoter system which may solve this problem. The system is based on the PIP-vectors which cqntain the T7 RNA polymerase gene under control of a promoter that inverts at random. When the promoter inverts to the ON position, T7 RNA polymerase is expressed which in turn directs expression of the gene of interest that has been positioned under the control of a T7 promoter on a second plasmid. The system can be stably maintained when a PIP vector is used that results in toxic antigen expression in only a minor part of the bacterial population.
In the present study we used the invertible promoter vectors pIP2 (=pYZ27bGP), pIP3 (=pYZ27GP), pIP4
' ( 
PBMC were stimululated with IO ,ug ml-' ConA for three days, washed and maintained in culture medium containing lOO@ml-' r-IL-2. The presence of FIV-antigen was detected using an antigen capture ELISA Immunogold labelling of SL326 1 -MFG4 demonstrated that about 40% of the bacteria expressed MBPGag ( Figure 5 ). This does not mean that all these expressing bacteria actually contain a PIP plasmid with the P, promoter in the ON position. It may be speculated that a number of these cells have been derived from cells that divided after a promoter inversion occurred, but before antigen expression reached a level that prevented further cell divisions.
The S. typhimurium vaccination strain SL3261 appeared to be immunogenic in cats. After i.p. as well as after oral immunization, high specific antibody titers to S. typhimurium LPS were induced. Moreover, SL3261 can also be used as a vector to present heterologous antigens to the immune system of cats, as high serum antibody titers were induced to CtxB and MBP. The responses to FIV Gag were considerably weaker. A second immunization was necessary to induce detectable Gag specific serum antibodies upon i.p. immunization. After two oral immunizations no Gag-specific antibodies were detected, but the immune system had clearly been primed for Gag protein recognition, as after FIV challenge Gag-specific antibodies could be detected two weeks earlier than in the control cats. It is unlikely that this is the result of enhancement of FIV infection, as we observed with other FIV vaccine candidates57, since the FIV loads of this cat at 33 and 67 days post challenge were even lower than those of the control cats. It should be stressed that the specific antibody responses were mainly determined as a marker to demonstrate that the heterologous antigens expressed by SL3261 are presented to the immune system of cats, since it cannot be expected that antibodies against the internal Gag proteins would neutralize FIV. In general S. typhimurium preferentially induces cellular immune responses, including cytotoxic T cell responses35m"8.40 which may contribute to protective immunity5'.
No FIV specific T cell responses were determined in the framework of these experiments. However, if indeed Gag specific T helper and CTL responses were induced by these immunizations, they were apparently not sufficient to protect the cats against the homologous challenge with 30 CID50 FIV. We are currently investigating the immune responses and priming effects in cats, immunized with SL3261 strains expressing the Gag and envelope proteins of FIV in order to generate a more complete immune response to FIV proteins that will hopefully result in protection. 
